TY - JOUR
T1 - Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS
AU - Guo, Cheng
AU - Che, Xiaoyu
AU - Briese, Thomas
AU - Ranjan, Amit
AU - Allicock, Orchid
AU - Yates, Rachel A.
AU - Cheng, Aaron
AU - March, Dana
AU - Hornig, Mady
AU - Komaroff, Anthony L.
AU - Levine, Susan
AU - Bateman, Lucinda
AU - Vernon, Suzanne D.
AU - Klimas, Nancy G.
AU - Montoya, Jose G.
AU - Peterson, Daniel L.
AU - Lipkin, W. Ian
AU - Williams, Brent L.
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/2/8
Y1 - 2023/2/8
N2 - Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by unexplained debilitating fatigue, cognitive dysfunction, gastrointestinal disturbances, and orthostatic intolerance. Here, we report a multi-omic analysis of a geographically diverse cohort of 106 cases and 91 healthy controls that revealed differences in gut microbiome diversity, abundances, functional pathways, and interactions. Faecalibacterium prausnitzii and Eubacterium rectale, which are both recognized as abundant, health-promoting butyrate producers in the human gut, were reduced in ME/CFS. Functional metagenomics, qPCR, and metabolomics of fecal short-chain fatty acids confirmed a deficient microbial capacity for butyrate synthesis. Microbiome-based machine learning classifier models were robust to geographic variation and generalizable in a validation cohort. The abundance of Faecalibacterium prausnitzii was inversely associated with fatigue severity. These findings demonstrate the functional nature of gut dysbiosis and the underlying microbial network disturbance in ME/CFS, providing possible targets for disease classification and therapeutic trials.
AB - Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by unexplained debilitating fatigue, cognitive dysfunction, gastrointestinal disturbances, and orthostatic intolerance. Here, we report a multi-omic analysis of a geographically diverse cohort of 106 cases and 91 healthy controls that revealed differences in gut microbiome diversity, abundances, functional pathways, and interactions. Faecalibacterium prausnitzii and Eubacterium rectale, which are both recognized as abundant, health-promoting butyrate producers in the human gut, were reduced in ME/CFS. Functional metagenomics, qPCR, and metabolomics of fecal short-chain fatty acids confirmed a deficient microbial capacity for butyrate synthesis. Microbiome-based machine learning classifier models were robust to geographic variation and generalizable in a validation cohort. The abundance of Faecalibacterium prausnitzii was inversely associated with fatigue severity. These findings demonstrate the functional nature of gut dysbiosis and the underlying microbial network disturbance in ME/CFS, providing possible targets for disease classification and therapeutic trials.
KW - Faecalibacterium
KW - biomarkers
KW - butyrate
KW - co-abundance network
KW - irritable bowel syndrome
KW - metabolomics
KW - microbiome
KW - myalgic encephalomyelitis/chronic fatigue syndrome
KW - short-chain fatty acids
KW - shotgun metagenomics
UR - https://www.scopus.com/pages/publications/85147568627
UR - https://www.scopus.com/pages/publications/85147568627#tab=citedBy
U2 - 10.1016/j.chom.2023.01.004
DO - 10.1016/j.chom.2023.01.004
M3 - Article
C2 - 36758522
AN - SCOPUS:85147568627
SN - 1931-3128
VL - 31
SP - 288-304.e8
JO - Cell Host and Microbe
JF - Cell Host and Microbe
IS - 2
ER -